According to Axogen's latest financial reports the company has $31.02 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $31.02 M | -36.41% |
2022-12-31 | $48.78 M | -41.98% |
2021-12-31 | $84.08 M | -19.12% |
2020-12-31 | $0.10 B | 7.73% |
2019-12-31 | $96.51 M | -17.23% |
2018-12-31 | $0.11 B | 219.4% |
2017-12-31 | $36.5 M | 21.63% |
2016-12-31 | $30.01 M | 15.84% |
2015-12-31 | $25.9 M | 215.36% |
2014-12-31 | $8.21 M | -59.06% |
2013-12-31 | $20.06 M | 44.31% |
2012-12-31 | $13.9 M | 69.79% |
2011-12-31 | $8.19 M | 355.28% |
2010-12-31 | $1.79 M | -88.59% |
2009-12-31 | $15.76 M | 4636.73% |
2008-12-31 | $0.33 M | -60.04% |
2007-12-31 | $0.83 M | -35.02% |
2006-12-31 | $1.28 M | -2.2% |
2005-12-31 | $1.31 M | -41.47% |
2004-12-31 | $2.23 M | 362.82% |
2003-12-31 | $0.48 M | -27.96% |
2002-12-31 | $0.67 M | -52.88% |
2001-12-31 | $1.42 M | |
2001-06-30 | $3.37 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
Medtronic MDT | $8.32 B | 26,721.17% | ๐ฎ๐ช Ireland |
Thermo Fisher Scientific TMO | $8.07 B | 25,934.68% | ๐บ๐ธ USA |
Boston Scientific BSX | $2.32 B | 7,407.09% | ๐บ๐ธ USA |